What Regulus Therapeutics Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Witz Pascale | Director | Jun 25 | Disposition to Issuer · D | −67,233 | — | — | 0 |
| Rastetter William H | Director | Jun 25 | Disposition to Issuer · D | −57,292 | — | — | 0 |
| Rastetter William H | Director | Jun 25 | Tender Offer · U | −44,264 | — | — | 57,292 |
| Papadopoulos Stelios | Director | Jun 25 | Disposition to Issuer · D | −64,635 | — | — | 0 |
| Papadopoulos Stelios | Director | Jun 25 | Tender Offer · U | −976,253 | — | — | 64,635 |
| Nunn Jason Raleigh | Director | Jun 25 | Disposition to Issuer · D | −62,500 | — | — | 0 |
| Calsada Crispina | Chief Financial Officer | Jun 25 | Disposition to Issuer · D | −140,228 | — | — | 0 |
| Collier Kathryn J | Director | Jun 25 | Disposition to Issuer · D | −75,565 | — | — | 0 |
| Huang Alice Shih-hou | Director | Jun 25 | Disposition to Issuer · D | −57,292 | — | — | 0 |
| Huang Alice Shih-hou | Director | Jun 25 | Tender Offer · U | −27,377 | — | — | 57,292 |
| Huang Alice Shih-hou | Director | Jun 25 | Disposition to Issuer · D | −57,292 | — | — | 0 |
| Huang Alice Shih-hou | Director | Jun 25 | Tender Offer · U | −5,208 | — | — | 57,292 |
| Baltimore David | Director | Jun 25 | Disposition to Issuer · D | −57,292 | — | — | 0 |
| Baltimore David | Director | Jun 25 | Tender Offer · U | −5,208 | — | — | 57,292 |
| Baltimore David | Director | Jun 25 | Disposition to Issuer · D | −57,292 | — | — | 0 |
| Baltimore David | Director | Jun 25 | Tender Offer · U | −27,377 | — | — | 57,292 |
| Hagan Joseph P | Chief Executive Officer | Jun 25 | Disposition to Issuer · D | −571,558 | — | — | 0 |
| Aker Christopher Ray | Sr. VP & General Counsel | Jun 25 | Disposition to Issuer · D | −83,125 | — | — | 0 |
| Aker Christopher Ray | Sr. VP & General Counsel | Jun 25 | Tender Offer · U | −60,796 | — | — | 83,125 |
| Klassen Preston | President & Head of R & D | Jun 25 | Disposition to Issuer · D | −115,555 | — | — | 0 |
Loading...
